While transcriptional regulation of collagen type I genes in response to ciprofloxacin treatment is mainly controlled via Fli1, other factors may contribute to ciprofloxacin-induced MMP1 upregulation and CCN2 repression, since the mRNA levels of these genes are altered in both SSc and normal fibroblasts. The gene discussed is FLI1; the disease is systemic sclerosis.